scispace - formally typeset
R

Rachel S. Kelly

Researcher at Brigham and Women's Hospital

Publications -  137
Citations -  3421

Rachel S. Kelly is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 26, co-authored 106 publications receiving 2466 citations. Previous affiliations of Rachel S. Kelly include Medical Research Council & Michigan State University.

Papers
More filters
Journal ArticleDOI

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

Sonja I. Berndt, +137 more
- 01 Aug 2013 - 
TL;DR: The largest meta-analysis for CLL thus far, including four GWAS with a total of 3,100 individuals with CLL (cases) and 7,667 controls, identified ten independent associated SNPs in nine new loci and found evidence for two additional promising loci below genome-wide significance.
Journal ArticleDOI

Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

Joshua N. Sampson, +448 more
TL;DR: Correlation analysis indicates that the genetic architecture of lung cancer differs between a smoking population of European ancestry and a nonsmoking Asian population, allowing for the possibility that the Genetic etiology for the same disease can vary by population and environmental exposures.

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

James R. Cerhan, +132 more
TL;DR: This paper conducted a meta-analysis of three new genome-wide association studies (GWAS) and 1 previous scan, totaling 3,857 cases and 7,666 controls of European ancestry, with additional genotyping of 9 promising SNPs in 1,359 cases and 4,557 controls.
Journal ArticleDOI

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.

James R. Cerhan, +132 more
- 01 Nov 2014 - 
TL;DR: Data provide substantial new evidence for genetic susceptibility to this B cell malignancy and point to pathways involved in immune recognition and immune function in the pathogenesis of DLBCL.